# hi-discovery Session Transcript: diabetes-ccm

This is an abbreviated worked example of a `session` mode interaction for the
topic `diabetes-ccm`. It illustrates the interactive research assistant loop,
access advisories, and the save checkpoint.

---

## Invocation

```
User: hi-discovery session diabetes-ccm
```

---

## Step 1 — Domain Advice

**Agent:**

> Starting discovery session for **diabetes-ccm**.
> 
> Checking topic status...
> ```
> hi status show diabetes-ccm
> ✓ Topic: diabetes-ccm (initialized)
>   Stage: initialized | Sources: 0 | Last updated: 2026-04-15
> ```
>
> No existing discovery plan found — starting fresh.
>
> ---
> **Domain Advice: Diabetes Chronic Care Management (CCM)**
>
> This topic sits at the intersection of several CMS programs and has a large
> quality measure footprint. Here's what to keep in mind as we build your source
> plan:
>
> **CMS Program Alignment**: T2D is covered by CMS122 (HbA1c Poor Control),
> mandatory in MIPS/QPP. CCM billing codes (CPT 99490–99491) are CMS-billable for
> eligible beneficiaries. ACO REACH and CPC+ models include diabetes components.
>
> **SDOH**: Food insecurity is the most evidence-backed SDOH driver of poor
> glycemic control. Gravity SDOH FHIR IG is relevant for interoperability planning.
>
> **Health Equity**: Documented disparities in Black, Hispanic/Latino, and AIAN
> populations. HEDIS now requires race/ethnicity stratification.
>
> **Terminology**: You'll need SNOMED CT (disease hierarchy), LOINC (HbA1c 4548-4,
> glucose 1558-6), ICD-10-CM (E08–E13), and RxNorm (metformin, insulin analogs).
>
> **Economics**: $327B annual US burden. Per-patient cost: $16,752 vs $6,153. I'll
> include a HCUP health-economics source — required for this chronic condition topic.

---

## Step 2 — PubMed + PMC Search

**Agent:**

> Running PubMed and PMC searches...
>
> ```
> hi search pubmed --query "chronic care model diabetes type 2 outcomes" --max 20 --json
> ```
> Retrieved 20 results. Top relevant:
> - Piatt et al. 2023, *Diabetes Care* — RCT, team-based CCM, HbA1c reduction
> - Stellefson et al. 2013, *Diabetes Educator* — CCM systematic review (grade-b)
>
> ```
> hi search pmc --query "chronic care model diabetes management" --max 20 --json
> ```
> Retrieved 18 open-access results. Top relevant:
> - PMC9876543 — "Pharmacist-led CCM in T2D" (open access, 2024)

---

## Step 3 — ClinicalTrials.gov

**Agent:**

> ```
> hi search clinicaltrials --query "diabetes chronic care management team-based" --max 20 --json
> ```
> Retrieved 12 results. 3 active trials in CCM-based T2D interventions identified.
> Adding 1 representative active trial as a `registry` type source.

---

## Step 4 — US Government Sources

**Agent:**

> Based on the topic, I'm adding these US government sources to the plan:
>
> - **CMS eCQM CMS122** (HbA1c Poor Control) — FHIR bundle, open access
> - **USPSTF Diabetes Screening** — Grade B recommendation, open access
> - **HCUP NIS** — cost data, open access summary statistics
> - **Gravity SDOH FHIR IG** — open access

---

## Step 7 — Source Plan Summary

**Agent:**

> Here is the proposed source plan (10 sources identified):
>
> | # | Name | Type | Evidence | Access | Notes |
> |---|------|------|----------|--------|-------|
> | 1 | ADA Standards of Care 2024 | guideline | grade-a | open | URL provided |
> | 2 | SNOMED CT — Diabetes Hierarchy | terminology | reference-standard | open | URL provided |
> | 3 | CMS eCQM CMS122 | measure-library | n/a | open | URL provided |
> | 4 | USPSTF Diabetes Screening | guideline | uspstf-b | open | URL provided |
> | 5 | Gravity SDOH FHIR IG | fhir-ig | reference-standard | open | URL provided |
> | 6 | HCUP NIS — Diabetes Hospitalizations | health-economics | n/a | open | URL provided |
> | 7 | Cochrane — Intensive Glycemic Control | systematic-review | grade-a | authenticated | library proxy |
> | 8 | LOINC HbA1c / Glucose codes | terminology | reference-standard | open | URL provided |
> | 9 | Diabetes Care Journal (CCM articles) | pubmed-article | grade-b | authenticated | library proxy |
> |10 | ICD-10-CM E08–E13 | terminology | reference-standard | open | URL provided |
>
> All open-access sources have URLs recorded. Authenticated sources are flagged
> with access advisories below. `hi-ingest` will handle all downloads and
> registration. Do you approve this list? Any changes?

**User:** Looks good, go ahead.

---

## Step 8 — Access Advisories

**Agent:**

> All 8 open-access sources have URLs recorded in the plan and will be fetched
> by `hi-ingest`. Here are the access advisories for sources requiring
> authentication or manual retrieval:
>
> ---
> ⊘ **Cochrane Review — Intensive Glycemic Control T2D**
>    Why relevant: Definitive systematic review for CCM glycemic target setting
>    Access URL:   https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008143.pub2
>    Auth method:  Institutional access via library proxy
>    Search terms: "intensive glycemic control type 2 diabetes cardiovascular"
>
> ⊘ **Diabetes Care Journal**
>    Why relevant: Primary specialty journal; key CCM RCTs published here
>    Access URL:   https://diabetesjournals.org/care
>    Auth method:  Institutional access or library proxy; use PubMed for abstracts
>    Search terms: "chronic care model diabetes effectiveness team-based"
>
> Once you have retrieved the authenticated sources, place them in `sources/`
> and run `hi-ingest session diabetes-ccm` — it will read this discovery plan
> and register everything in one pass.

---

## Step 9 — Research Expansion Suggestions

**Agent:**

> Here are 5 adjacent areas worth exploring:
>
> 1. **Diabetic Kidney Disease Prevention** — T2D is the leading cause of ESRD.
>    `hi search pubmed --query "diabetic kidney disease SGLT2 CKD prevention" --max 15`
>
> 2. **Medication Adherence Economics** — GLP-1 and insulin adherence gaps drive
>    hospitalizations; pharmacist-led programs are cost-effective.
>    `hi search pubmed --query "diabetes medication adherence cost effectiveness" --max 10`
>
> 3. **Health Equity in Underserved Populations** — FQHC/safety-net burden is
>    disproportionate; HRSA UDS benchmarks are available.
>    `hi search pubmed --query "diabetes disparities racial ethnic minority FQHC" --max 10`
>
> 4. **CGM Integration and Interoperability** — CMS LCD for CGM is evolving;
>    SMART on FHIR CGM apps are emerging.
>    `hi search clinicaltrials --query "continuous glucose monitoring type 2 diabetes" --max 10`
>
> 5. **CCM Implementation Barriers** — Known workflow and EHR barriers; CFIR/RE-AIM
>    frameworks applied to diabetes CCM.
>    `hi search pubmed --query "chronic care model implementation barriers primary care" --max 10`

---

## Step 10 — Interactive Prompt

**Agent:**

> **Next steps — please choose:**
>
> A) Explore an expansion area (tell me which number)
> B) Modify the source list
> C) Save the current plan
> D) Run verify after saving

**User:** C — save the plan.

---

## Step 11 — Save Checkpoint

**Agent:**

> Saving discovery plan...
>
> ✓ Written: `topics/diabetes-ccm/process/plans/discovery-plan.md`
>   (10 sources: 8 open, 2 authenticated)
>
> ✓ Updated: `topics/diabetes-ccm/process/research.md`
>   (10 sources → Pending Review, awaiting hi-ingest)
>
> ✓ Updated: `RESEARCH.md` (row for diabetes-ccm: sources=10, updated=2026-04-15)
>
> ✓ Created: `topics/diabetes-ccm/process/conflicts.md` (stub)
>
> ---
> Run `hi-discovery verify diabetes-ccm` to validate the plan, then
> `hi-ingest session diabetes-ccm` to fetch and register all sources.

---

## verify Mode Output

```
User: hi-discovery verify diabetes-ccm
```

```
hi validate --plan topics/diabetes-ccm/process/plans/discovery-plan.md
```

```
Validating: topics/diabetes-ccm/process/plans/discovery-plan.md

✓ YAML frontmatter parses successfully
✓ Source count: 10 (within 5–25 range)
✓ At least one terminology source present (SNOMED CT, LOINC, ICD-10-CM)
✓ All sources have non-empty rationale
✓ All sources have non-empty search_terms
✓ All evidence_level values are valid
⚠ 1 source has unrecognized type (custom-registry) — review recommended
✓ Health-economics source present (HCUP NIS)

Overall: PASS (1 warning)
```

> Plan passed validation with 1 warning. You may proceed to `hi-ingest`.
